XML 61 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes
12 Months Ended
Oct. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes
14.
Income Taxes
Loss before provision for income taxes consisted of the following:
 
    
Year ended October 31,
 
    
2023
    
2022
 
Domestic (Canada)
  
$
(99,157
  
$
(23,965
Foreign (US)
    
(743
    
(475
  
 
 
    
 
 
 
Loss before provision for income taxes
  
$
(99,900
  
$
(24,440
  
 
 
    
 
 
 
 
 
The components of the provision for income taxes is as follows:
 
    
Year ended October 31,
 
    
2023
    
2022
 
Current expense (benefit):
     
Domestic (Canada)
  
$
— 
    
$
— 
 
Foreign (US)
    
17
      
22
 
  
 
 
    
 
 
 
Total current expense (benefit)
    
17
      
22
 
  
 
 
    
 
 
 
Deferred expense (benefit)
     
Domestic (Canada)
    
— 
      
— 
 
Foreign (US)
    
— 
      
— 
 
  
 
 
    
 
 
 
Total deferred tax expense (benefit)
    
— 
      
— 
 
  
 
 
    
 
 
 
Total income tax expense (benefit)
  
$
17
    
$
22
 
  
 
 
    
 
 
 
A reconciliation of the Company’s statutory income tax rate to the Company’s effective income tax rate is as follows:
 
    
Year ended October 31,
 
    
2023
   
2022
 
Income at Canada statutory rate
    
26.50
   
26.50
Conversion of debentures
    
(21.90
)% 
   
— 
 
State taxes, net of federal benefit
    
0.05
   
0.12
Permanent differences
    
1.68
   
(3.90
)% 
Tax credits
    
0.19
   
0.29
Foreign rate differential
    
(0.04
)% 
   
(0.11
)% 
Valuation allowance
    
(6.52
)% 
   
(22.86
)% 
Other
    
0.03
   
(0.14
)% 
  
 
 
   
 
 
 
    
(0.01
)% 
   
(0.09
)% 
  
 
 
   
 
 
 
The net deferred income tax balances related to the following:
 
    
October 31,
 
    
2023
    
2022
 
Deferred tax assets:
     
R&D expenditures
    
7,012
      
6,441
 
Net operating loss (NOL) carryforwards
    
18,918
      
13,862
 
ITC credits
    
1,210
      
963
 
Property and equipment
    
791
      
742
 
Convertible debenture embedded derivative liabilities
    
— 
      
13
 
Financing costs
    
2,440
      
— 
 
Accruals
    
149
      
101
 
Section 174 capitalized R&D costs
    
393
      
— 
 
Other
    
172
      
— 
 
  
 
 
    
 
 
 
Total deferred tax assets
    
31,085
      
22,122
 
  
 
 
    
 
 
 
 
 
    
October 31,
 
    
2023
    
2022
 
Valuation allowance
    
(31,085
    
(22,048
  
 
 
    
 
 
 
Net deferred tax assets (liability)
    
— 
      
74
 
  
 
 
    
 
 
 
Deferred tax liabilities:
     
Convertible debentures
    
— 
      
(9
Other
    
— 
      
(65
  
 
 
    
 
 
 
Total deferred tax liabilities
    
— 
      
(74
  
 
 
    
 
 
 
Net deferred tax assets (liability)
    
— 
      
— 
 
  
 
 
    
 
 
 
The calculation of the Company’s tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations for both federal taxes and the provinces and states in which the Company operates or does business in. ASC 740 states that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, on the basis of the technical merits.
The Company records uncertain tax positions as liabilities in accordance with ASC 740 and adjusts these liabilities when the Company’s judgment changes as a result of the evaluation of new information not previously available. Because of the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from the current estimate of the unrecognized tax benefit liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which new information is available. As of October 31, 2023 and 2022, no uncertain tax positions have been recorded in the consolidated financial statements.
The Company recognizes interest and penalties related to unrecognized tax benefits on the income tax expense line in the accompanying consolidated statement of operations and comprehensive loss. As of October 31, 2023 and 2022, no accrued interest or penalties are included on the related tax liability line in the consolidated balance sheet.
As of October 31, 2023, the Company has Canadian Federal NOL carryforwards of $71.9 million, that expire between 2028 and 2043 and Canadian provincial NOL carryforwards of $68.5 million, that expire between 2031 and 2043. As of October 31, 2023, the Company has a U.S. Federal NOL carryforward of $0.9 million, that may be carried forward indefinitely, and a U.S. state NOL carryforward of $0.5 million, that begin to expire in 2039.
As of October 31, 2023, the Company also has Canadian investment tax credits of $1.8 million that expire between 2028 and 2043.